Cargando…
ERBB2 Amplification as a Predictive and Prognostic Biomarker in Upper Tract Urothelial Carcinoma
SIMPLE SUMMARY: Upper tract urothelial carcinomas (UTUCs) occur in about 5–10% of all urothelial carcinomas and are frequently discovered in high-stage disease. We aimed to evaluate human epidermal growth factor receptor 2 (ERBB2) protein expression and ERBB2 amplification in UTUCs according to the...
Autores principales: | Zimpfer, Annette, Kdimati, Said, Mosig, Melanie, Rudolf, Henrik, Zettl, Heike, Erbersdobler, Andreas, Hakenberg, Oliver W., Maruschke, Matthias, Schneider, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177383/ https://www.ncbi.nlm.nih.gov/pubmed/37173881 http://dx.doi.org/10.3390/cancers15092414 |
Ejemplares similares
-
The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification
por: Schneider, Björn, et al.
Publicado: (2022) -
Comparing tumor microRNA profiles of patients with long- and short-term-surviving glioblastoma
por: Schneider, Björn, et al.
Publicado: (2022) -
Management of Upper Tract Urothelial Carcinoma
por: Smith, Norm D.
Publicado: (2009) -
HPV Infection, but Not EBV or HHV-8 Infection, Is Associated with Salivary Gland Tumours
por: Hühns, Maja, et al.
Publicado: (2015) -
Endoscopic Management of Upper Tract Urothelial Carcinoma
por: Moore, K., et al.
Publicado: (2009)